About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

A Study Of PF-04449913 Administered Alone In Select Solid Tumors

NCT01286467·9 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Pfizer

Age

18–99

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Histological or cytological diagnosis of advanced/metastatic solid tumor
Adequate Bone Marrow Function
Adequate Renal Function
Adequate Liver Function

You may not be if

Patients with known symptomatic brain metastases requiring steroids
Current active treatment on another clinical trial
Major surgery or radiation therapy within 4-weeks of starting study treatment

The record

StatusCompleted

PhasePhase 1

Taking part23

StartedMay 2011

UpdatedMar 6, 2024

Conditions

Where9

Keck Hospital of University of Southern California
Los Angeles, California, United States
Los Angeles County-University of Southern California Medical Center
Los Angeles, California, United States
University of Southern California/Norris Comprehensive Cancer Center/Investigational Drug Service
Los Angeles, California, United States

Clareo Health | A Study Of PF-04449913 Administered Alone In Select Solid Tumors